Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Celldex Therapeutics revenue
Celldex Therapeutics's revenue is $7.0 million.
What is Celldex Therapeutics's revenue?
- Celldex Therapeutics's revenue growth from 2000 to 2024 is 819.81%.
- Celldex Therapeutics has 134 employees, and the revenue per employee ratio is $52,388.
- Celldex Therapeutics's peak quarterly revenue was $37.7M in 2010(q4).
- Celldex Therapeutics peak revenue was $46.8M in 2010.
- Celldex Therapeutics annual revenue for 2023 was 6.9M, 192.02% growth from 2022.
- Celldex Therapeutics annual revenue for 2024 was 7.0M, 1.99% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Celldex Therapeutics historical revenue
Celldex Therapeutics's peak revenue was $46.8M in 2010. The peak quarterly revenue was $37.7M in 2010(q4).
Celldex Therapeutics's revenue increased from $763.2k in 2000 to $7.0M currently. That's a 819.81% change in annual revenue.
Celldex Therapeutics annual revenue
Celldex Therapeutics annual revenue over time
| Fiscal year / year | Celldex Therapeutics revenue |
|---|---|
| 2009 | $15.2M |
| 2010 | $46.8M |
| 2011 | $9.3M |
| 2012 | $11.2M |
| 2013 | $4.1M |
| 2014 | $3.6M |
| 2015 | $5.5M |
| 2016 | $6.8M |
| 2017 | $12.7M |
| 2018 | $9.5M |
| 2019 | $3.6M |
| 2020 | $7.4M |
| 2021 | $4.7M |
| 2022 | $2.4M |
| 2023 | $6.9M |
| 2024 | $7.0M |
Rate Celldex Therapeutics' financial transparency
Celldex Therapeutics annual growth
Celldex Therapeutics saw the greatest revenue growth in 2008, when revenue increased by 430.3%.
Celldex Therapeutics had the lowest revenue growth in 2011, when revenue changed by -80.2%.
Celldex Therapeutics annual growth rate over time
| Year | Celldex Therapeutics growth |
|---|---|
| 2009 | 104%↑ |
| 2010 | 208%↑ |
| 2011 | -80%↓ |
| 2012 | 21%↑ |
| 2013 | -63%↓ |
| 2014 | -13%↓ |
| 2015 | 53%↑ |
| 2016 | 24%↑ |
| 2017 | 88%↑ |
| 2018 | -25%↓ |
| 2019 | -63%↓ |
| 2020 | 108%↑ |
| 2021 | -37%↓ |
| 2022 | -49%↓ |
| 2023 | 192%↑ |
| 2024 | 2%↑ |
Celldex Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Celldex Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $3.7M | $2.7M | $4.0M | $4.7M |
| 2010 | $3.7M | $3.0M | $2.4M | $37.7M |
| 2011 | $2.5M | $2.0M | $2.4M | $2.4M |
| 2012 | $2.4M | $2.0M | $3.1M | $3.6M |
| 2013 | $2.4M | $97,000 | $980,000 | $620,000 |
| 2014 | $416,000 | $592,000 | $1.1M | $1.5M |
| 2015 | $486,000 | $2.2M | $1.0M | $1.8M |
| 2016 | $1.3M | $1.4M | $2.2M | $1.9M |
| 2017 | $1.5M | $3.8M | $3.9M | $3.5M |
| 2018 | $4.1M | $2.8M | $941,000 | $1.8M |
| 2019 | $1.4M | $715,000 | $546,000 | $887,000 |
| 2020 | $2.7M | $236,000 | $668,000 | $3.8M |
| 2021 | $685,000 | $3.5M | $153,000 | $334,000 |
| 2022 | $174,000 | $163,000 | $407,000 | $1.6M |
| 2023 | $967,000 | $268,000 | $1.5M | $4.1M |
| 2024 | $156,000 | $2.5M | $3.2M | $1.2M |
Celldex Therapeutics jobs nearby
Do you work at Celldex Therapeutics?
Is Celldex Therapeutics transparent about its revenue structure?
Celldex Therapeutics financial information
| CEO | Anthony S. Marucci |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 134 |
| Date Founded | 1983 |
| Headquarters | Hampton, New Jersey |
| Number of Locations | 3 |
| Revenue | $7.0M |
| Net Income | -$112,325,000 |
| Gross Proft | $6.7M (2002) |
| EBITDA | ($35.7M) (2009) |
| PE Ratio | -0.28 |
| Tax Rate | 0.0% |
| Market Capitalization | $44.9M |
| Total Assets | $352,735,000 |
| Ticker | CLDX |
Celldex Therapeutics jobs you might like
Celldex Therapeutics financing
Celldex Therapeutics received early financing of $90.0M on 2013-02-04.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $90M | 02/2013 |
| Post Ipo Equity | $171.5M | 12/2013 |
| Post Ipo Equity | $2M | 10/2014 |
| Post Ipo Equity | $174M | 02/2015 |
| Post Ipo Equity | $150M | 06/2020 |
| Post Ipo Equity | $287.5M | 07/2021 |
Celldex Therapeutics competitors
Celldex Therapeutics's top competitor, Emergent BioSolutions, earned an annual revenue of $1.6B.
Celldex Therapeutics's smallest competitor is Altea Therapeutics with revenue of $320.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Acadia Pharmaceuticals | $90,533 | $957.8M | 570 | 108 |
| Puma Biotechnology | $91,110 | $230.5M | 265 | 7 |
| ImmunoCellular Therapeutics | $45,932 | $1.6M | 4 | - |
| Amyris | $82,561 | $269.8M | 595 | - |
| Zyomyx | $53,983 | $840,000 | 5 | - |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 11 |
| Morphotek | $51,282 | $4.8M | 1 | - |
| T2 Biosystems | $76,239 | $7.2M | 182 | - |
| ABC Laboratories | $72,507 | $72.0M | 3,000 | 3 |
| Micell Technologies | $49,709 | $3.1M | 14 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Celldex Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Celldex Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Celldex Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Celldex Therapeutics. The data presented on this page does not represent the view of Celldex Therapeutics and its employees or that of Zippia.
Celldex Therapeutics may also be known as or be related to CELLDEX THERAPEUTICS INC., Celldex Therapeutics, Celldex Therapeutics Inc, Celldex Therapeutics, Inc. and Celldex Therapeutics, Inc. (Old).